Cita APA

Asnani, A., Zheng, B., Liu, Y., Wang, Y., Chen, H. H., Vohra, A., . . . Peterson, R. T. (2018). Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity. JCI Insight.

Chicago Style Citation

Asnani, Aarti, et al. "Highly Potent Visnagin Derivatives Inhibit Cyp1 and Prevent Doxorubicin Cardiotoxicity." JCI Insight 2018.

Cita MLA

Asnani, Aarti, et al. "Highly Potent Visnagin Derivatives Inhibit Cyp1 and Prevent Doxorubicin Cardiotoxicity." JCI Insight 2018.